GL1X · GenesisL1 explorer

MolNFT v1 · #179659 · protein

Crystal structure of human methionine adenosyltransferase 2A (MAT2A) in complex with SAM and allosteric inhibitor ag-270

7KCC · S-adenosylmethionine synthase isoform type-2: “Crystal structure of human methionine adenosyltransferase 2A (MAT2A) in complex with SAM and allosteric…”. X-ray diffraction, 3 ligands (SAM, WBG, CL), 2 pockets (best druggability…

PDB
7KCC
Type
protein
Length
382 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
S-adenosylmethionine synthase isoform type-2
EC
2.5.1.6
UniProt
P31153
Ligands
SAM, WBG, CL
Pockets
2 · best druggability 0.37

Structure

x-ray diffraction · 1 distinct chain · 33% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AS-adenosylmethionine synthase isoform type-2 (EC 2.5.1.6)protein38233% helix, 26% strandP31153

Ligands and binding sites

  • SAM · S-adenosylmethionine · ligand · chains A
  • WBG · 3-(cyclohex-1-en-1-yl)-6-(4-methoxyphenyl)-2-phenyl-5-[(pyridin-2-yl)amino]pyrazolo[1,5-a]pyrimidin-7(4H)-one · ligand · chains A
  • CL · Chloride ion · ion · 2 copies · chains A
  • EDO · 1,2-ethanediol · additive · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1870.370.7619empty
2670.340.7721empty

Compared structures

  • 7KCC · Crystal structure of human methionine adenosyltransferase 2A (MAT2A) in complex with SAM… · the same entry in another collection · chain A against A, TM-score 1.00
  • P31153 · AlphaFold monomer V2.0 prediction for S-adenosylmethionine synthase isoform type-2… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.